| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,573 |
1,569 |
$143K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,888 |
1,760 |
$137K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,706 |
1,700 |
$106K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,545 |
1,445 |
$83K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,133 |
1,079 |
$28K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,213 |
600 |
$15K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
882 |
858 |
$11K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
135 |
133 |
$4K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
70 |
70 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
399 |
387 |
$3K |
| 99000 |
|
1,292 |
1,236 |
$964.08 |
| 81002 |
|
340 |
329 |
$849.17 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
63 |
60 |
$737.96 |
| 87634 |
|
16 |
16 |
$581.30 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
14 |
14 |
$59.47 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
31 |
29 |
$34.29 |
| 99051 |
|
365 |
357 |
$0.00 |